Terry Myerson, Truveta CEO

Big da­ta meets Big Phar­ma: Pfiz­er buys re­al-time pa­tient re­sults in col­lab­o­ra­tion with Tru­ve­ta

Ter­ry My­er­son led one of the most prof­itable arms of Mi­crosoft dur­ing his 21-year tenure there, hav­ing a hand in the de­vel­op­ment of Win­dows and Xbox soft­ware. But My­er­son start­ed out as a pre-med stu­dent be­fore all of that and turned to life sci­ences in­vest­ing af­ter his stint at Mi­crosoft end­ed in 2018.

My­er­son is now the CEO of Tru­ve­ta, a for-prof­it da­ta ven­ture backed by 20 US health sys­tems, which was seed­ed from a project My­er­son was work­ing on in the midst of the pan­dem­ic with Prov­i­dence, a hos­pi­tal sys­tem on the West Coast. Tru­ve­ta an­nounced to­day a part­ner­ship with Pfiz­er, one that gives the Big Phar­ma ac­cess to re­al-time da­ta on some 50 mil­lion de-iden­ti­fied pa­tients.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.